Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-19 · Built: 2026-10-19 · 中文

← United States · Coverage record

US · SEC FORM 4

Odyssey Therapeutics, Inc.

ODTX · Nasdaq · CIK 0001882782 · Healthcare · Biotechnology

INSIDER SIGNAL

84.2 / 100

7 buyers · 9 purchase transaction lines · $75.3M gross purchase

WHY THIS SIGNAL?

Buyer breadthStrong
Purchase sizeStrong
RoleModerate
RecencyLow
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+35.0 / 35
Purchase size+24.5 / 25
Role+14.0 / 20
Recency+0.7 / 10
Conviction+10.0 / 10

What is holding the score back?

  • ⚠ Role scores low · most senior buyer: Other (CEO, chair and 10% owners score lowest)
  • ⚠ Purchase activity is becoming less recent
  • ✓ Cluster breadth is broad · 4+ insiders

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Purchase breadth & concentration

QUALIFYING BUYERS7
PURCHASE CONCENTRATION33%Largest buyer: COULTER JAMES G; TPG GP A, LLC; WINKELRIED JON · $25.0M
CLUSTER BUYING · 15D7 insidersPeak activity: 2026-05-08–2026-05-11

Roles in the peak window: Chief Financial Officer, Director, Other, TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
George Simeon; SR ONE CAPITAL MANAGEMENT, LLCTenPercentOwner
○●▼○
LEIDEN JEFFREY MDirector
●○○○
COULTER JAMES G; TPG GP A, LLC; WINKELRIED JONOther
○○●
Opipari Anthony W.See Remarks
○○○
Li Nan (LN)Director
○●
Dimension Capital II, L.P.Director
○●
● Purchase▼ Sale○ Other

Showing the six most active owners; 3 additional owner(s) remain in Form 4 evidence.

SIGNAL HISTORY

84.2 / 100

Latest recorded score

→ +0.0 ptsversus the previous recorded snapshot
  1. 84.2
  2. 84.2
  3. 84.2
  4. 84.2
  5. 84.2

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

9Purchases
3Sales
27Other Form 4 lines
9SEC filings · 365 days
BUYING9 qualifying P line(s) · 180 days
SELLING3 sale line(s) · context only
OTHER27 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
-19.6%
3M
+7.9%
6M
—
12M
—

Volatility & liquidity

Volatility
72.1%
Beta
—
Avg daily value
USD 5.1M

Valuation

Market cap
USD 912.6M
P/E
—

Fundamentals

Profit margin
—
ROE
—
Industry
Biotechnology

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-06-12 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
3,105,465
Previous report
2,208,686
Avg daily volume
551,207
Days to cover
5.6

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-05-11COULTER JAMES G; TPG GP A, LLC; WINKELRIED JONPurchase (P)Common Stock1,388,889USD 18.00USD 25,000,002SEC filing ↗
2026-05-11Li Nan (LN)Purchase (P)Common Stock1,111,111USD 18.00USD 19,999,998SEC filing ↗
2026-05-11George Simeon; SR ONE CAPITAL MANAGEMENT, LLCPurchase (P)Common Stock555,555USD 18.00USD 9,999,990SEC filing ↗
2026-05-11Chu ShelleyPurchase (P)Common Stock11,111USD 18.00USD 199,998SEC filing ↗
2026-05-08Dimension Capital II, L.P.Purchase (P)Common Stock1,111,111USD 18.00USD 19,999,998SEC filing ↗
2026-05-08LEIDEN JEFFREY MPurchase (P)Common Stock5,000USD 20.00USD 100,000SEC filing ↗
2026-05-08Haas JasonPurchase (P)Common Stock1,000USD 20.00USD 20,000SEC filing ↗

Form 4 evidence

39 transaction lines in the latest 365-day window; 39 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-05-11COULTER JAMES G; TPG GP A, LLC; WINKELRIED JONPurchase (P)Common Stock1,388,889USD 18.00USD 25,000,002SEC filing ↗
2026-05-11COULTER JAMES G; TPG GP A, LLC; WINKELRIED JONJ (J)Common Stock425,462USD —USD —SEC filing ↗
2026-05-11COULTER JAMES G; TPG GP A, LLC; WINKELRIED JONC (C)Common Stock1,880,497USD —USD —SEC filing ↗
Show recent Form 4 evidence (21 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-05-11COULTER JAMES G; TPG GP A, LLC; WINKELRIED JONPurchase (P)Common Stock1,388,889USD 18.00USD 25,000,002SEC filing ↗
2026-05-11COULTER JAMES G; TPG GP A, LLC; WINKELRIED JONJ (J)Common Stock425,462USD —USD —SEC filing ↗
2026-05-11COULTER JAMES G; TPG GP A, LLC; WINKELRIED JONC (C)Common Stock1,880,497USD —USD —SEC filing ↗
2026-05-11Opipari Anthony W.Option exercise / conversion (M)Common Stock541USD —USD —SEC filing ↗
2026-05-11Opipari Anthony W.Tax withholding (F)Common Stock4USD 18.00USD 72SEC filing ↗
2026-05-11Opipari Anthony W.C (C)Common Stock6,965USD —USD —SEC filing ↗
2026-05-11Li Nan (LN)Purchase (P)Common Stock1,111,111USD 18.00USD 19,999,998SEC filing ↗
2026-05-11Li Nan (LN)C (C)Common Stock1,709,543USD —USD —SEC filing ↗
2026-05-11LEIDEN JEFFREY MOption exercise / conversion (M)Common Stock2,963USD —USD —SEC filing ↗
2026-05-11LEIDEN JEFFREY MTax withholding (F)Common Stock17USD 18.00USD 306SEC filing ↗
2026-05-11LEIDEN JEFFREY MC (C)Common Stock28,698USD —USD —SEC filing ↗
2026-05-11Glick Gary DC (C)Common Stock27,386USD —USD —SEC filing ↗
2026-05-11George Simeon; SR ONE CAPITAL MANAGEMENT, LLCX (X)Common Stock320,047USD —USD —SEC filing ↗
2026-05-11George Simeon; SR ONE CAPITAL MANAGEMENT, LLCSale (S)Common Stock1,780USD 18.00USD 32,040SEC filing ↗
2026-05-11George Simeon; SR ONE CAPITAL MANAGEMENT, LLCPurchase (P)Common Stock555,555USD 18.00USD 9,999,990SEC filing ↗
2026-05-11George Simeon; SR ONE CAPITAL MANAGEMENT, LLCC (C)Common Stock2,921,061USD —USD —SEC filing ↗
2026-05-11Chu ShelleyPurchase (P)Common Stock11,111USD 18.00USD 199,998SEC filing ↗
2026-05-08Dimension Capital II, L.P.Purchase (P)Common Stock1,111,111USD 18.00USD 19,999,998SEC filing ↗
2026-05-08Dimension Capital II, L.P.C (C)Common Stock1,709,543USD —USD —SEC filing ↗
2026-05-08LEIDEN JEFFREY MPurchase (P)Common Stock5,000USD 20.00USD 100,000SEC filing ↗
2026-05-08Haas JasonPurchase (P)Common Stock1,000USD 20.00USD 20,000SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-19
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerODTX
CIK0001882782
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2836 Biological Products, (No Diagnostic Substances)
ExchangeNasdaq

Data coverage

Local Form 4 history39 transaction lines from 2026-05-08 to 2026-05-11
9 P purchase lines · 3 S sale lines · 27 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.